Optimal Wound Healing Strategies for Gastric and Colon Surgery
Apply closed-incision negative-pressure wound therapy (cINPT) to high-risk surgical incisions, continue biologic therapy perioperatively in IBD patients, and provide preoperative immunonutrition for 5-7 days in malnourished patients to optimize wound healing and reduce surgical site infections. 1
Incisional Wound Management
Negative-Pressure Wound Therapy (NPWT)
- Use cINPT for all high-risk abdominal incisions to reduce surgical site infections by 58% (from 12.5% to 5.2%), wound dehiscence by 29%, and hospital length of stay by 0.47 days 1
- The effect is most pronounced in contaminated/dirty wounds, where infection rates drop from 37% with primary closure to 0% with vacuum-assisted closure 1
- Double-ring wound protectors are superior to single-ring devices (RR 0.29 vs 0.71) for open procedures 1
- Apply NPWT immediately postoperatively and maintain for at least 5-7 days 1
Common pitfall: Avoid using prophylactic drains after appendectomy or colorectal surgery for complicated cases, as they increase hospital stay and 30-day morbidity without preventing intra-abdominal abscesses 1
Perioperative Medication Management
Biologic Therapy Continuation
- Continue anti-TNF and other biologic agents throughout the perioperative period in IBD patients, as they do not increase surgical site infections or anastomotic complications 1, 2
- The PUCCINI study (955 operations) confirmed that preoperative biologic exposure and detectable drug levels before surgery were not associated with increased infectious complications 1
- For bevacizumab in cancer patients, stop at least 6 weeks before elective surgery (2 half-lives) to avoid wound healing complications 1
Corticosteroid Management
- Taper corticosteroids to below 20 mg prednisolone equivalent preoperatively when possible 2
- Provide intravenous hydrocortisone perioperatively for patients on chronic steroids (prednisolone 5 mg = hydrocortisone 20 mg) 2
Critical caveat: High-dose steroids (>20 mg prednisolone) increase risk of anastomotic leaks and infectious complications, but abrupt discontinuation may trigger disease flare 2
Nutritional Optimization
Preoperative Immunonutrition
- Administer oral nutritional supplements enriched with arginine, omega-3 fatty acids, and nucleotides for 5-7 days preoperatively in malnourished patients undergoing major gastric or colorectal surgery 1
- This reduces postoperative infectious complications (from 23.8% to 10.7%, p=0.0007) and hospital length of stay 1
- Continue immunonutrition for 5 days postoperatively when integrated into ERAS protocols 1
- For gastric cancer specifically, early enteral nutrition with immunomodulating formula reduces wound-healing problems, suture failure, and infectious complications 1
ERAS Protocol Implementation
- Start early oral nutrition on the day of surgery 3
- Limit preoperative fasting to 6 hours for solids and 2 hours for liquids 2
- Consider carbohydrate loading 2 hours before anesthesia 2
Important distinction: While immunonutrition shows clear benefits in malnourished patients, evidence in well-nourished patients is mixed, with some studies showing no advantage 1
Anastomotic Healing Considerations
Factors Impairing Anastomotic Integrity
- Avoid NSAIDs in the immediate postoperative period for patients with colon or rectal anastomoses, as they correlate with dehiscence and wound healing inhibition 1
- Male gender, peritonitis, smoking, comorbidity, and perioperative blood loss independently predict tissue and wound complications 4
- Emergency operations carry 2.7-fold higher risk of wound complications compared to elective surgery (16% vs 6%) 4
Protective Measures
- Maintain normothermia intraoperatively to decrease SSI rates 1
- Use antibacterial sutures for fascial closure 1
- Ensure adequate antibiotic redosing during prolonged procedures based on pharmacokinetic/pharmacodynamic principles 1
Risk Stratification Algorithm
High-risk patients requiring maximal intervention (apply all measures above):
- Emergency surgery for peritonitis 1, 4
- Incision length ≥20 cm (15-fold increased SSI risk) 5
- Malnourished patients (BMI <18.5 or >10% weight loss) 3, 2
- Active smokers 4
- Patients on chronic corticosteroids 2
Moderate-risk patients (selective intervention):
- Elective colorectal surgery in well-nourished patients 1
- IBD patients on biologics (continue therapy, add wound protection) 1, 2
- Contaminated but not dirty wounds 1
Standard-risk patients (routine ERAS protocol):